# Promising Medicines for ME/CFS — Call Drug Repurposing

**Funder:** ZonMw
**Budget:** €600k–€1M per project (total pool €3.5M)
**Deadline:** 8 September 2026 (Deadline for detailed grant application: 8 September 2026, 14:00 CEST. Pre-selection project idea deadline was 17 March 2026 (passed). Full timeline: advisory committee review mid-June 2026, referee comments 14 October 2026, response deadline 4 November 2026, decision February 2027.)
**Duration:** Up to 4 years
**Consortium:** No
**Application:** 2-stage: project idea (pre-proposal, deadline passed 17 March 2026) → detailed grant application (8 September 2026)
**Frequency:** One-off
**Eligible countries:** NL
**Official call:** https://www.zonmw.nl/en/subsidy/promising-medicines-mecfs-call-drug-repurposing
**Last verified:** 14 June 2026

## Eligibility & scope

Funds clinical research (Proof of Concept or Clinical Validation studies) into drug repurposing of existing off-patent medicines for ME/CFS patients in the Netherlands. Applicants must be Dutch legal entities (public or private law). Non-research organisations must provide ≥50% co-financing. Proposals must be submitted in English via My ZonMw.

---

Source: [The Great Grantsby](https://grantsby.eu/grants/zonmw-promising-medicines-for-me-cfs-call-drug-repurposi-2026-09) — EU grant monitoring for academic researchers. Always verify details on the funder's website before applying.